Personalis Comprehensive Income 2018-2024 | PSNL
Personalis comprehensive income from 2018 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Personalis Annual Comprehensive Income
(Millions of US $) |
| 2023 |
$-0 |
| 2022 |
$-1 |
| 2021 |
$-0 |
| 2020 |
$0 |
| 2019 |
$-0 |
| 2018 |
$-0 |
| 2017 |
$ |
Personalis Quarterly Comprehensive Income
(Millions of US $) |
| 2024-09-30 |
$0 |
| 2024-06-30 |
$-0 |
| 2024-03-31 |
$-0 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$-0 |
| 2023-06-30 |
$-0 |
| 2023-03-31 |
$-0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-1 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-1 |
| 2021-12-31 |
$-0 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$0 |
| 2021-03-31 |
$-0 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$-0 |
| 2019-09-30 |
$-0 |
| 2019-06-30 |
$-0 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.396B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
